All News

There are a lot of factors that go into medication errors-pharmacists are stepping up, but the FDA must also act.

A new FDA plan will offer new education opportunities for a variety of healthcare workers.

Pharmacists add value, but you need to show that to health-system executives.

What one pharmacist says he wishes he’d prioritized sooner.

The opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.

Why one pharmacist thinks pharmacy education is being wasted.

Drug errors generally fall into one of four categories-here's how the experts say those errors can be eliminated. 

A massive retrospective study compared several non-vitamin K antagonist oral anticoagulants (NOACs) to warfarin.

Tall man lettering is supposed to help reduce medication errors-but some say it doesn’t go far enough.

Why pharmacists need to be paying attention to the Trinity II case and its consequences.

The FDA recently approved cannabidiol oral solution to treat seizures.

Stalled competition hurts consumers and may keep prices higher.

1.1 million Americans live with HIV-here’s how you can help.

How pharmacists can help students get the treatments they need.

Drug Topics recently spoke with the FDA about the role pharmacists can play in patient education.

The EpiPen shortage is putting lives at risk and creating a back-up at some pharmacies. But solutions are on the horizon.

The annual report on generic access and savings shows some impressive numbers for 2017.

The latest New Drug Review covers Amgen’s migraine medication.

What the experts have to say about recent shifts in pharmacy law and practice.

An unclear naming system for biosimilars could affect patient safety.

Small Doses is back, bringing you the pharmacy news you need in a way that works for you.

Turns out running a bar shares many similarities with running a pharmacy-but the mistakes cost a lot more.

How new technologies are enabling pharmacies to increase adherence and their bottom line.

The drug is the first approved under the agency's new, quicker generic approval designation.

Interested in cardiology? Here’s why you should consider becoming extra training and certification.

It’s time to fix the disconnect between what students are taught and what’s needed to practice.